Wright Medical And Tornier See A Desirable Partner Choose Another (Seeking Alpha)
Summary
Stryker was expected to be a buyer in the extremities market, but its choice of Small Bone Innovations was a little surprising.
Stryker now has a credible presence in the upper and lower extremity markets, and can use its considerable R&D and marketing prowess to leverage that further.
Losing Stryker as a potential buyer arguably hurts Tornier more, but suggests that Wright Medical could get $35 or more per share from Johnson & Johnson or Zimmer.
It may be a little extreme to diagnose the med-...
